Europe Gastric Cancer Diagnostic Procedure Market Forecast to 2028 –Regional Analysis – by Healthcare Providers (Diagnostic Laboratories, Hospitals, Cancer Research Institutes, Oncology Specialty Clinics, and Others), Symptom Types (Symptomatic and Asymptomatic), Body Fluid (Blood, Urine, Saliva, Stomach Wash/Gastric Juice, Tissue, and Others), Procedures (Endoscopic Procedures, Biopsy & Tissue Tests, Lab Tests, In-Vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics & Immunoassays, and Others), Offering [Instruments, Reagents & Consumables (Including Kits), and Services], Disease Indication (Early Gastric Cancer and Advanced Gastric Cancer), and Country
The Europe gastric cancer diagnostic procedure market was valued at US$ 464.72 million in 2022 and is projected to reach US$ 674.76 million by 2028. It is estimated to grow at a CAGR of 6.4% from 2022 to 2028.
Rise in Prevalence of Gastrointestinal Diseases Fuels Europe Gastric Cancer Diagnostic Procedure Market
Heartburn, inflammatory bowel diseases (IBD), inflammatory bowel syndrome (IBS), constipation, and diarrhea are among the common digestive problems. Gastrointestinal (GI) diseases account for substantial healthcare utilization and spending. The stomach is lined with a mucous membrane composed of cells and glands. The cells are prone to inflammation, leading to peptic ulcers, which may potentially develop into gastric cancer. Problems caused by stomach acid backflowing into the esophagus, known as gastroesophageal reflux disease (GERD), also increase the risk of developing gastric cancer. Despite declining incidence and mortality during the last decades, stomach cancer is perceived as one of the main health challenges. The prevalence of irritable bowel syndrome (IBS) has increased across the region in the last few decades. In contrast to a decline in the overall incidence of gastric cancer, it has surged among young adults in the last few decades. Thus, the increasing prevalence of gastrointestinal (GI) disease results in a high risk of developing gastric cancer, which drives the growth of the gastric cancer diagnostic procedures market.
Europe Gastric Cancer Diagnostic Procedure Market Overview
The Europe gastric cancer diagnostic procedure market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant share of the global gastric cancer diagnostic procedure market. The market in Europe is expected to witness significant growth during the forecast period due to factors such as the high incidence of stomach cancer and Helicobacter pylori infection, growth in the geriatric population, and efforts made by various institutes to spread awareness of gastric cancer. Germany is one of the fastest-growing markets for gastric cancer diagnostic procedures in Europe. According to The Robert Koch Institute, H. pylori and Epstein-Barr virus infections are reported to be the major cause of stomach cancer. Germany reports a high incidence of H. pylori infection. According to a study published in Clinical Microbiology and Infection Journal (ELSEVIER) in 2020, H. pylori infected ~25% of the total population in Germany and caused gastritis that becomes more complicated with gastric adenocarcinoma.
Exhibit: Europe Gastric Cancer Diagnostic Procedure Market Revenue and Forecast to 2028
(US$ Million)
Europe Gastric Cancer Diagnostic Procedure Market Segmentation
The Europe gastric cancer diagnostic procedure market is segmented into healthcare provider, symptom type, body fluid, procedure, offering, disease indication, and country.
Based on healthcare provider, the Europe gastric cancer diagnostic procedure market is segmented into diagnostic laboratories, hospitals, cancer research institutes, oncology specialty clinics, and others. The hospitals segment held the largest market share in 2022. In terms of body fluid, the Europe gastric cancer diagnostic procedure market is segmented into blood, urine, saliva, stomach wash/gastric juice, tissue, and others. The blood segment held the largest market share in 2022. The Europe gastric cancer diagnostic procedure market, by offering, is segmented into instruments, reagents & consumables, and services. The reagents & consumables segment held the largest market share in 2022.
Based on diagnostic procedure, the Europe gastric cancer diagnostic procedure market is categorized into endoscopic procedures, biopsy and tissue tests, lab tests, in-vitro diagnostic tests, imaging tests, molecular diagnostics, multiplexing molecular diagnostics, immunoassays, and others. The imaging segment held the largest share of the market in 2022. The Europe gastric cancer diagnostic procedure market, based on disease condition, is bifurcated into early gastric cancer and advanced type gastric cancer. The advanced type gastric cancer segment held a larger market share in 2022.
Based on country, the Europe gastric cancer diagnostic procedure market has been categorized into the UK, Germany, France, Italy, Spain, and Rest of Europe. Germany dominated the market in this region in 2022.
Agilent Technologies Inc, Atlas-Link Biotech Co Ltd, BioMerieux SA, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd, Illumina Inc, Myraid Genetics Inc, Thermo Fisher Scientific Inc, and Vela Diagnostics Holding Pte Ltd. are the leading companies operating in the Europe gastric cancer diagnostic procedure market.
Rise in Prevalence of Gastrointestinal Diseases Fuels Europe Gastric Cancer Diagnostic Procedure Market
Heartburn, inflammatory bowel diseases (IBD), inflammatory bowel syndrome (IBS), constipation, and diarrhea are among the common digestive problems. Gastrointestinal (GI) diseases account for substantial healthcare utilization and spending. The stomach is lined with a mucous membrane composed of cells and glands. The cells are prone to inflammation, leading to peptic ulcers, which may potentially develop into gastric cancer. Problems caused by stomach acid backflowing into the esophagus, known as gastroesophageal reflux disease (GERD), also increase the risk of developing gastric cancer. Despite declining incidence and mortality during the last decades, stomach cancer is perceived as one of the main health challenges. The prevalence of irritable bowel syndrome (IBS) has increased across the region in the last few decades. In contrast to a decline in the overall incidence of gastric cancer, it has surged among young adults in the last few decades. Thus, the increasing prevalence of gastrointestinal (GI) disease results in a high risk of developing gastric cancer, which drives the growth of the gastric cancer diagnostic procedures market.
Europe Gastric Cancer Diagnostic Procedure Market Overview
The Europe gastric cancer diagnostic procedure market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant share of the global gastric cancer diagnostic procedure market. The market in Europe is expected to witness significant growth during the forecast period due to factors such as the high incidence of stomach cancer and Helicobacter pylori infection, growth in the geriatric population, and efforts made by various institutes to spread awareness of gastric cancer. Germany is one of the fastest-growing markets for gastric cancer diagnostic procedures in Europe. According to The Robert Koch Institute, H. pylori and Epstein-Barr virus infections are reported to be the major cause of stomach cancer. Germany reports a high incidence of H. pylori infection. According to a study published in Clinical Microbiology and Infection Journal (ELSEVIER) in 2020, H. pylori infected ~25% of the total population in Germany and caused gastritis that becomes more complicated with gastric adenocarcinoma.
Exhibit: Europe Gastric Cancer Diagnostic Procedure Market Revenue and Forecast to 2028
(US$ Million)
Europe Gastric Cancer Diagnostic Procedure Market Segmentation
The Europe gastric cancer diagnostic procedure market is segmented into healthcare provider, symptom type, body fluid, procedure, offering, disease indication, and country.
Based on healthcare provider, the Europe gastric cancer diagnostic procedure market is segmented into diagnostic laboratories, hospitals, cancer research institutes, oncology specialty clinics, and others. The hospitals segment held the largest market share in 2022. In terms of body fluid, the Europe gastric cancer diagnostic procedure market is segmented into blood, urine, saliva, stomach wash/gastric juice, tissue, and others. The blood segment held the largest market share in 2022. The Europe gastric cancer diagnostic procedure market, by offering, is segmented into instruments, reagents & consumables, and services. The reagents & consumables segment held the largest market share in 2022.
Based on diagnostic procedure, the Europe gastric cancer diagnostic procedure market is categorized into endoscopic procedures, biopsy and tissue tests, lab tests, in-vitro diagnostic tests, imaging tests, molecular diagnostics, multiplexing molecular diagnostics, immunoassays, and others. The imaging segment held the largest share of the market in 2022. The Europe gastric cancer diagnostic procedure market, based on disease condition, is bifurcated into early gastric cancer and advanced type gastric cancer. The advanced type gastric cancer segment held a larger market share in 2022.
Based on country, the Europe gastric cancer diagnostic procedure market has been categorized into the UK, Germany, France, Italy, Spain, and Rest of Europe. Germany dominated the market in this region in 2022.
Agilent Technologies Inc, Atlas-Link Biotech Co Ltd, BioMerieux SA, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd, Illumina Inc, Myraid Genetics Inc, Thermo Fisher Scientific Inc, and Vela Diagnostics Holding Pte Ltd. are the leading companies operating in the Europe gastric cancer diagnostic procedure market.
1. INTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Gastric cancer diagnostic procedure Market – by Healthcare Providers
1.3.2 Europe Gastric Cancer Diagnostic Procedure Market – By Symptom Types
1.3.3 Europe Gastric Cancer Diagnostic Procedure Market – By Body Fluid
1.3.4 Europe Gastric Cancer Diagnostic Procedure Market – By Procedures
1.3.5 Europe Gastric Cancer Diagnostic Procedure Market – By Offerings
1.3.6 Europe Gastric Cancer Diagnostic Procedure Market – By Disease Indication
1.3.7 Europe Gastric cancer diagnostic procedure Market – by Country
2. EUROPE GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. EUROPE GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe PEST Analysis
4.2.2 Expert’s Opinion
5. EUROPE GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Rise in Prevalence of Gastrointestinal Diseases
5.1.2 Surging Cases of Helicobacter Pylori Infection
5.2 Market Restraints
5.2.1 Shortage of Medical Laboratory Professionals
5.3 Market Opportunities
5.3.1 Rising Awareness of Gastric Cancer
5.4 Future Trends
5.4.1 Development of AI-Based Gastric Cancer Diagnostic Platform
5.5 Impact Analysis
6. EUROPE GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – EUROPE ANALYSIS
6.1 Europe Gastric Cancer Diagnostic Procedure Market Revenue Forecast and Analysis
7. EUROPE GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – REVENUE AND FORECAST TO 2028 – BY HEALTHCARE PROVIDERS
7.1 Overview
7.2 Diagnostic Laboratories
7.2.1 Overview
7.2.2 Diagnostic Laboratories: Europe Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million)
7.3 Hospitals
7.3.1 Overview
7.3.2 Hospitals: Europe Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million)
7.4 Cancer Research Institutes
7.4.1 Overview
7.4.2 Cancer Research Institutes: Europe Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Oncology Specialty Clinics
7.5.1 Overview
7.5.2 Oncology Specialty Clinics: Europe Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Europe Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
8. EUROPE GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET ANALYSIS AND FORECASTS TO 2028 – BY SYMPTOM TYPES
8.1 Overview
8.2 Symptomatic
8.2.1 Overview
8.2.2 Symptomatic: Europe Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
8.3 Asymptomatic
8.3.1 Overview
8.3.2 Asymptomatic: Europe Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
9. EUROPE GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – REVENUE AND FORECAST TO 2028 – BY BODY FLUID
9.1 Overview
9.2 Blood
9.2.1 Overview
9.2.2 Blood: Europe Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
9.3 Urine
9.3.1 Overview
9.3.2 Urine: Europe Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
9.4 Saliva
9.4.1 Overview
9.4.2 Saliva: Europe Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
9.5 Stomach Wash/Gastric Juice
9.5.1 Overview
9.5.2 Stomach Wash/Gastric Juice: Europe Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
9.6 Tissue
9.6.1 Overview
9.6.2 Tissue: Europe Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Other: Europe Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
10. EUROPE GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – REVENUE AND FORECAST TO 2028 – BY PROCEDURE
10.1 Overview
10.2 Endoscopic Procedure
10.2.1 Overview
10.2.2 Endoscopic Procedure: Europe Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million)
10.3 Biopsy and Tissue Tests
10.3.1 Overview
10.3.2 Biopsy and Tissue Tests: Europe Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million)
10.4 Lab Tests
10.4.1 Overview
10.4.2 Lab Tests: Europe Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
10.5 In-Vitro Diagnostic Tests
10.5.1 Overview
10.5.2 In-Vitro Diagnostic Tests: Europe Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
10.6 Imaging Tests
10.6.1 Overview
10.6.2 Imaging Tests: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
10.7 Molecular Diagnostics
10.7.1 Overview
10.7.2 Molecular Diagnostics: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
10.8 Multiplexing Molecular Diagnostics and Immunoassay
10.8.1 Overview
10.8.2 Multiplexing Molecular Diagnostics and Immunoassay: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
10.9 Others
10.9.1 Overview
10.9.2 Others: Europe Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
11. EUROPE GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – REVENUE AND FORECAST TO 2028 – BY OFFERINGS
11.1 Overview
11.2 Instruments
11.2.1 Overview
11.2.2 Instruments: Europe Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
11.3 Reagents and Consumables
11.3.1 Overview
11.3.2 Reagents and Consumables: Europe Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
11.4 Services
11.4.1 Overview
11.4.2 Services: Europe Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
12. EUROPE GASTRIC CANCER DIAGNOSTIC PROCEDURE ANALYSIS – BY DISEASE INDICATION
12.1 Overview
12.2 Early Gastric Cancer
12.2.1 Overview
12.2.2 Early Gastric Cancer: Europe Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
12.3 Gastric Cancer Advanced Types
12.3.1 Overview
12.3.2 Gastric Cancer Advanced Types: Europe Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
13. EUROPE: GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET
13.1 Overview
13.1.1 Europe: Gastric Cancer Diagnostic Procedure Market, by Country
13.1.1.1 Germany: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.1.1 Overview
13.1.1.1.2 Europe Germany Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.1.3 Germany Gastric cancer diagnostic procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.1.1.1.3.1 Germany Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.1.1.1.3.2 Germany Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.1.1.1.3.3 Germany Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.1.1.1.3.4 Germany Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.1.1.1.4 Germany Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.1.1.1.5 Germany Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.1.1.1.6 Germany Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.1.1.1.6.1 Germany Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.1.1.1.6.2 Germany Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.1.1.1.6.3 Germany Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.1.1.1.6.4 Germany Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.1.1.1.6.5 Germany Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.1.1.1.7 Germany Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.1.1.1.8 Germany Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.1.1.2 France: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.2.1 Overview
13.1.1.2.2 France: Gastric cancer diagnostic procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.2.3 France: Gastric Cancer Diagnostic Procedure Market, by Healthcare providers, 2019–2028 (US$ Million)
13.1.1.2.3.1 France: Europe Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.1.1.2.3.2 France: Europe Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.1.1.2.3.3 France: Europe Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.1.1.2.3.4 France: Europe Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.1.1.2.4 France: Europe Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.1.1.2.5 France: Europe Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.1.1.2.6 France: Europe Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.1.1.2.6.1 France: Europe Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.1.1.2.6.2 France: Europe Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.1.1.2.6.3 France: Europe Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.1.1.2.6.4 France: Europe Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.1.1.2.6.5 France: Europe Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.1.1.2.7 France Europe Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.1.1.2.8 France Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.1.1.3 UK: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.3.1 Overview
13.1.1.3.2 UK: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.3.3 UK: Europe Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.1.1.3.3.1 UK: Europe Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.1.1.3.3.2 UK: Europe Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.1.1.3.3.3 UK: Europe Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.1.1.3.3.4 UK: Europe Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.1.1.3.4 UK: Europe Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.1.1.3.5 UK: Europe Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.1.1.3.6 UK: Europe Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.1.1.3.6.1 UK: Europe Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.1.1.3.6.2 UK: Europe Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.1.1.3.6.3 UK: Europe Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.1.1.3.6.4 UK: Europe Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.1.1.3.6.5 UK: Europe Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.1.1.3.7 UK: Europe Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.1.1.3.8 UK: Europe Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.1.1.4 Italy: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.4.1 Overview
13.1.1.4.2 Italy: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.4.3 Italy: Europe Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.1.1.4.3.1 Italy: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.1.1.4.3.2 Italy: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.1.1.4.3.3 Italy: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.1.1.4.3.4 Italy: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.1.1.4.4 Italy: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.1.1.4.5 Italy: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.1.1.4.6 Italy: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.1.1.4.6.1 Italy: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.1.1.4.6.2 Italy: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.1.1.4.6.3 Italy: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.1.1.4.6.4 Italy: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.1.1.4.6.5 Italy: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.1.1.4.7 Italy: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.1.1.4.8 Italy: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.1.1.5 Spain: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.5.1 Overview
13.1.1.5.2 Spain: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.5.3 Spain: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.1.1.5.3.1 Spain: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.1.1.5.3.2 Spain: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.1.1.5.3.3 Spain: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.1.1.5.3.4 Spain: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.1.1.5.4 Spain: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.1.1.5.5 Spain: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.1.1.5.6 Spain: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.1.1.5.6.1 Spain: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.1.1.5.6.2 Spain: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.1.1.5.6.3 Spain: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.1.1.5.6.4 Spain: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.1.1.5.6.5 Spain: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.1.1.5.7 Spain: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.1.1.5.8 Spain: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.1.1.6 Rest of Europe: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.6.1 Overview
13.1.1.6.2 Rest of Europe: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.6.3 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.1.1.6.3.1 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.1.1.6.3.2 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.1.1.6.3.3 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.1.1.6.3.4 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.1.1.6.4 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.1.1.6.5 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.1.1.6.6 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.1.1.6.6.1 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.1.1.6.6.2 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.1.1.6.6.3 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.1.1.6.6.4 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.1.1.6.6.5 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.1.1.6.7 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.1.1.6.8 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
14. INDUSTRY LANDSCAPE
14.1 Overview
14.2 Organic Developments
14.2.1 Overview
14.3 Inorganic Developments
14.3.1 Overview
15. COMPANY PROFILES
15.1 Atlas-Link Biotech Co Ltd
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 Bio-Rad Laboratories Inc
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5
15.2.6 SWOT Analysis
15.2.7 Key Developments
15.3 Agilent Technologies Inc
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 F. Hoffmann-La Roche Ltd
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 bioMerieux SA
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Thermo Fisher Scientific Inc
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Illumina Inc
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 Vela Diagnostics Holding Pte Ltd
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 Myraid Genetics Inc
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
16. APPENDIX
16.1 About The Insight Partners
16.2 Glossary of Terms
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Gastric cancer diagnostic procedure Market – by Healthcare Providers
1.3.2 Europe Gastric Cancer Diagnostic Procedure Market – By Symptom Types
1.3.3 Europe Gastric Cancer Diagnostic Procedure Market – By Body Fluid
1.3.4 Europe Gastric Cancer Diagnostic Procedure Market – By Procedures
1.3.5 Europe Gastric Cancer Diagnostic Procedure Market – By Offerings
1.3.6 Europe Gastric Cancer Diagnostic Procedure Market – By Disease Indication
1.3.7 Europe Gastric cancer diagnostic procedure Market – by Country
2. EUROPE GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. EUROPE GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe PEST Analysis
4.2.2 Expert’s Opinion
5. EUROPE GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Rise in Prevalence of Gastrointestinal Diseases
5.1.2 Surging Cases of Helicobacter Pylori Infection
5.2 Market Restraints
5.2.1 Shortage of Medical Laboratory Professionals
5.3 Market Opportunities
5.3.1 Rising Awareness of Gastric Cancer
5.4 Future Trends
5.4.1 Development of AI-Based Gastric Cancer Diagnostic Platform
5.5 Impact Analysis
6. EUROPE GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – EUROPE ANALYSIS
6.1 Europe Gastric Cancer Diagnostic Procedure Market Revenue Forecast and Analysis
7. EUROPE GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – REVENUE AND FORECAST TO 2028 – BY HEALTHCARE PROVIDERS
7.1 Overview
7.2 Diagnostic Laboratories
7.2.1 Overview
7.2.2 Diagnostic Laboratories: Europe Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million)
7.3 Hospitals
7.3.1 Overview
7.3.2 Hospitals: Europe Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million)
7.4 Cancer Research Institutes
7.4.1 Overview
7.4.2 Cancer Research Institutes: Europe Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Oncology Specialty Clinics
7.5.1 Overview
7.5.2 Oncology Specialty Clinics: Europe Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Europe Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
8. EUROPE GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET ANALYSIS AND FORECASTS TO 2028 – BY SYMPTOM TYPES
8.1 Overview
8.2 Symptomatic
8.2.1 Overview
8.2.2 Symptomatic: Europe Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
8.3 Asymptomatic
8.3.1 Overview
8.3.2 Asymptomatic: Europe Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
9. EUROPE GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – REVENUE AND FORECAST TO 2028 – BY BODY FLUID
9.1 Overview
9.2 Blood
9.2.1 Overview
9.2.2 Blood: Europe Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
9.3 Urine
9.3.1 Overview
9.3.2 Urine: Europe Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
9.4 Saliva
9.4.1 Overview
9.4.2 Saliva: Europe Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
9.5 Stomach Wash/Gastric Juice
9.5.1 Overview
9.5.2 Stomach Wash/Gastric Juice: Europe Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
9.6 Tissue
9.6.1 Overview
9.6.2 Tissue: Europe Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Other: Europe Gastric Cancer Diagnostic Procedure Market– Revenue and Forecast to 2028 (US$ Million)
10. EUROPE GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – REVENUE AND FORECAST TO 2028 – BY PROCEDURE
10.1 Overview
10.2 Endoscopic Procedure
10.2.1 Overview
10.2.2 Endoscopic Procedure: Europe Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million)
10.3 Biopsy and Tissue Tests
10.3.1 Overview
10.3.2 Biopsy and Tissue Tests: Europe Gastric Cancer Diagnostic Procedure – Revenue and Forecast to 2028 (US$ Million)
10.4 Lab Tests
10.4.1 Overview
10.4.2 Lab Tests: Europe Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
10.5 In-Vitro Diagnostic Tests
10.5.1 Overview
10.5.2 In-Vitro Diagnostic Tests: Europe Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
10.6 Imaging Tests
10.6.1 Overview
10.6.2 Imaging Tests: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
10.7 Molecular Diagnostics
10.7.1 Overview
10.7.2 Molecular Diagnostics: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
10.8 Multiplexing Molecular Diagnostics and Immunoassay
10.8.1 Overview
10.8.2 Multiplexing Molecular Diagnostics and Immunoassay: Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
10.9 Others
10.9.1 Overview
10.9.2 Others: Europe Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
11. EUROPE GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET – REVENUE AND FORECAST TO 2028 – BY OFFERINGS
11.1 Overview
11.2 Instruments
11.2.1 Overview
11.2.2 Instruments: Europe Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
11.3 Reagents and Consumables
11.3.1 Overview
11.3.2 Reagents and Consumables: Europe Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
11.4 Services
11.4.1 Overview
11.4.2 Services: Europe Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
12. EUROPE GASTRIC CANCER DIAGNOSTIC PROCEDURE ANALYSIS – BY DISEASE INDICATION
12.1 Overview
12.2 Early Gastric Cancer
12.2.1 Overview
12.2.2 Early Gastric Cancer: Europe Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
12.3 Gastric Cancer Advanced Types
12.3.1 Overview
12.3.2 Gastric Cancer Advanced Types: Europe Gastric Cancer Diagnostic Procedures Market – Revenue and Forecast to 2028 (US$ Million)
13. EUROPE: GASTRIC CANCER DIAGNOSTIC PROCEDURE MARKET
13.1 Overview
13.1.1 Europe: Gastric Cancer Diagnostic Procedure Market, by Country
13.1.1.1 Germany: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.1.1 Overview
13.1.1.1.2 Europe Germany Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.1.3 Germany Gastric cancer diagnostic procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.1.1.1.3.1 Germany Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.1.1.1.3.2 Germany Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.1.1.1.3.3 Germany Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.1.1.1.3.4 Germany Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.1.1.1.4 Germany Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.1.1.1.5 Germany Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.1.1.1.6 Germany Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.1.1.1.6.1 Germany Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.1.1.1.6.2 Germany Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.1.1.1.6.3 Germany Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.1.1.1.6.4 Germany Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.1.1.1.6.5 Germany Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.1.1.1.7 Germany Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.1.1.1.8 Germany Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.1.1.2 France: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.2.1 Overview
13.1.1.2.2 France: Gastric cancer diagnostic procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.2.3 France: Gastric Cancer Diagnostic Procedure Market, by Healthcare providers, 2019–2028 (US$ Million)
13.1.1.2.3.1 France: Europe Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.1.1.2.3.2 France: Europe Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.1.1.2.3.3 France: Europe Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.1.1.2.3.4 France: Europe Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.1.1.2.4 France: Europe Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.1.1.2.5 France: Europe Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.1.1.2.6 France: Europe Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.1.1.2.6.1 France: Europe Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.1.1.2.6.2 France: Europe Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.1.1.2.6.3 France: Europe Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.1.1.2.6.4 France: Europe Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.1.1.2.6.5 France: Europe Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.1.1.2.7 France Europe Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.1.1.2.8 France Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.1.1.3 UK: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.3.1 Overview
13.1.1.3.2 UK: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.3.3 UK: Europe Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.1.1.3.3.1 UK: Europe Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.1.1.3.3.2 UK: Europe Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.1.1.3.3.3 UK: Europe Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.1.1.3.3.4 UK: Europe Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.1.1.3.4 UK: Europe Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.1.1.3.5 UK: Europe Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.1.1.3.6 UK: Europe Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.1.1.3.6.1 UK: Europe Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.1.1.3.6.2 UK: Europe Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.1.1.3.6.3 UK: Europe Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.1.1.3.6.4 UK: Europe Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.1.1.3.6.5 UK: Europe Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.1.1.3.7 UK: Europe Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.1.1.3.8 UK: Europe Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.1.1.4 Italy: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.4.1 Overview
13.1.1.4.2 Italy: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.4.3 Italy: Europe Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.1.1.4.3.1 Italy: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.1.1.4.3.2 Italy: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.1.1.4.3.3 Italy: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.1.1.4.3.4 Italy: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.1.1.4.4 Italy: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.1.1.4.5 Italy: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.1.1.4.6 Italy: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.1.1.4.6.1 Italy: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.1.1.4.6.2 Italy: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.1.1.4.6.3 Italy: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.1.1.4.6.4 Italy: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.1.1.4.6.5 Italy: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.1.1.4.7 Italy: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.1.1.4.8 Italy: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.1.1.5 Spain: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.5.1 Overview
13.1.1.5.2 Spain: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.5.3 Spain: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.1.1.5.3.1 Spain: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.1.1.5.3.2 Spain: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.1.1.5.3.3 Spain: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.1.1.5.3.4 Spain: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.1.1.5.4 Spain: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.1.1.5.5 Spain: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.1.1.5.6 Spain: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.1.1.5.6.1 Spain: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.1.1.5.6.2 Spain: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.1.1.5.6.3 Spain: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.1.1.5.6.4 Spain: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.1.1.5.6.5 Spain: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.1.1.5.7 Spain: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.1.1.5.8 Spain: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
13.1.1.6 Rest of Europe: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.6.1 Overview
13.1.1.6.2 Rest of Europe: Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
13.1.1.6.3 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers, 2019–2028 (US$ Million)
13.1.1.6.3.1 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories, 2019–2028 (US$ Million)
13.1.1.6.3.2 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Hospitals, 2019–2028 (US$ Million)
13.1.1.6.3.3 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes, 2019–2028 (US$ Million)
13.1.1.6.3.4 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers, 2019–2028 (US$ Million)
13.1.1.6.4 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Symptom Types, 2019–2028 (US$ Million)
13.1.1.6.5 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Body Fluid, 2019–2028 (US$ Million)
13.1.1.6.6 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Procedures, 2019–2028 (US$ Million)
13.1.1.6.6.1 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures, 2019–2028 (US$ Million)
13.1.1.6.6.2 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Lab Tests, 2019–2028 (US$ Million)
13.1.1.6.6.3 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests, 2019–2028 (US$ Million)
13.1.1.6.6.4 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Imaging Tests, 2019–2028 (US$ Million)
13.1.1.6.6.5 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics, 2019–2028 (US$ Million)
13.1.1.6.7 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Offerings, 2019–2028 (US$ Million)
13.1.1.6.8 Rest of Europe: Gastric Cancer Diagnostic Procedure Market, by Disease Indication, 2019–2028 (US$ Million)
14. INDUSTRY LANDSCAPE
14.1 Overview
14.2 Organic Developments
14.2.1 Overview
14.3 Inorganic Developments
14.3.1 Overview
15. COMPANY PROFILES
15.1 Atlas-Link Biotech Co Ltd
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 Bio-Rad Laboratories Inc
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5
15.2.6 SWOT Analysis
15.2.7 Key Developments
15.3 Agilent Technologies Inc
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 F. Hoffmann-La Roche Ltd
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 bioMerieux SA
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Thermo Fisher Scientific Inc
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Illumina Inc
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 Vela Diagnostics Holding Pte Ltd
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 Myraid Genetics Inc
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
16. APPENDIX
16.1 About The Insight Partners
16.2 Glossary of Terms
LIST OF TABLES
Table 1. Germany Gastric cancer diagnostic procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million)
Table 3. Germany Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million)
Table 5. Germany Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million)
Table 6. Germany Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million)
Table 7. Germany Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million)
Table 8. Germany Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 9. Germany Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 10. Germany Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million)
Table 11. Germany Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million)
Table 12. Germany Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million)
Table 13. Germany Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)
Table 14. Germany Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million)
Table 15. Germany Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 16. France Gastric Cancer Diagnostic Procedure Market, by Healthcare providers – Revenue and Forecast to 2028 (US$ Million)
Table 17. France: Europe Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million)
Table 18. France : Europe Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million)
Table 19. France Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million)
Table 20. France Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million)
Table 21. France Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million)
Table 22. France Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million)
Table 23. France Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 24. France Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 25. France Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million)
Table 26. France Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million)
Table 27. France Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million)
Table 28. France Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)
Table 29. France : Europe Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million)
Table 30. France Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 31. UK Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million)
Table 32. UK Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million)
Table 33. UK Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million)
Table 34. UK Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million)
Table 35. UK Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million)
Table 36. UK Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million)
Table 37. UK Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million)
Table 38. UK Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 39. UK Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 40. UK Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million)
Table 41. UK Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million)
Table 42. UK Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million)
Table 43. UK Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)
Table 44. UK Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million)
Table 45. UK Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 46. Italy Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million)
Table 47. Italy Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million)
Table 48. Italy Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million)
Table 49. Italy Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million)
Table 50. Italy Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million)
Table 51. Italy Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million)
Table 52. Italy Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million)
Table 53. Italy Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 54. Italy Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 55. Italy Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million)
Table 56. Italy Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million)
Table 57. Italy Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million)
Table 58. Italy Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)
Table 59. Italy Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million)
Table 60. Italy Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 61. Spain Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million)
Table 62. Spain Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million)
Table 63. Spain Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million)
Table 64. Spain Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million)
Table 65. Spain Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million)
Table 66. Spain Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million)
Table 67. Spain Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million)
Table 68. Spain Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 69. Spain Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 70. Spain Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million)
Table 71. Spain Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million)
Table 72. Spain Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million)
Table 73. Spain Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)
Table 74. Spain Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million)
Table 75. Spain Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 76. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million)
Table 77. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million)
Table 78. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million)
Table 79. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million)
Table 80. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million)
Table 81. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million)
Table 82. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million)
Table 83. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 84. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 85. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million)
Table 86. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million)
Table 87. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million)
Table 88. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)
Table 89. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million)
Table 90. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 91. Organic Developments Done by Companies
Table 92. Inorganic Developments Done by Companies
Table 93. Glossary of Terms
Table 1. Germany Gastric cancer diagnostic procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million)
Table 3. Germany Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million)
Table 5. Germany Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million)
Table 6. Germany Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million)
Table 7. Germany Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million)
Table 8. Germany Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 9. Germany Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 10. Germany Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million)
Table 11. Germany Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million)
Table 12. Germany Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million)
Table 13. Germany Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)
Table 14. Germany Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million)
Table 15. Germany Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 16. France Gastric Cancer Diagnostic Procedure Market, by Healthcare providers – Revenue and Forecast to 2028 (US$ Million)
Table 17. France: Europe Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million)
Table 18. France : Europe Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million)
Table 19. France Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million)
Table 20. France Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million)
Table 21. France Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million)
Table 22. France Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million)
Table 23. France Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 24. France Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 25. France Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million)
Table 26. France Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million)
Table 27. France Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million)
Table 28. France Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)
Table 29. France : Europe Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million)
Table 30. France Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 31. UK Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million)
Table 32. UK Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million)
Table 33. UK Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million)
Table 34. UK Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million)
Table 35. UK Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million)
Table 36. UK Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million)
Table 37. UK Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million)
Table 38. UK Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 39. UK Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 40. UK Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million)
Table 41. UK Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million)
Table 42. UK Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million)
Table 43. UK Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)
Table 44. UK Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million)
Table 45. UK Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 46. Italy Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million)
Table 47. Italy Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million)
Table 48. Italy Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million)
Table 49. Italy Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million)
Table 50. Italy Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million)
Table 51. Italy Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million)
Table 52. Italy Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million)
Table 53. Italy Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 54. Italy Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 55. Italy Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million)
Table 56. Italy Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million)
Table 57. Italy Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million)
Table 58. Italy Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)
Table 59. Italy Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million)
Table 60. Italy Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 61. Spain Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million)
Table 62. Spain Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million)
Table 63. Spain Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million)
Table 64. Spain Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million)
Table 65. Spain Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million)
Table 66. Spain Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million)
Table 67. Spain Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million)
Table 68. Spain Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 69. Spain Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 70. Spain Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million)
Table 71. Spain Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million)
Table 72. Spain Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million)
Table 73. Spain Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)
Table 74. Spain Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million)
Table 75. Spain Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 76. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Healthcare Providers – Revenue and Forecast to 2028 (US$ Million)
Table 77. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Diagnostic Laboratories – Revenue and Forecast to 2028 (US$ Million)
Table 78. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Hospitals – Revenue and Forecast to 2028 (US$ Million)
Table 79. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Cancer Research Institutes – Revenue and Forecast to 2028 (US$ Million)
Table 80. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Oncology Specialty Centers – Revenue and Forecast to 2028 (US$ Million)
Table 81. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Symptom Types – Revenue and Forecast to 2028 (US$ Million)
Table 82. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Body Fluid – Revenue and Forecast to 2028 (US$ Million)
Table 83. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 84. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Endoscopic Procedures – Revenue and Forecast to 2028 (US$ Million)
Table 85. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Lab Tests – Revenue and Forecast to 2028 (US$ Million)
Table 86. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by In Vitro Diagnostics Tests – Revenue and Forecast to 2028 (US$ Million)
Table 87. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Imaging Tests – Revenue and Forecast to 2028 (US$ Million)
Table 88. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)
Table 89. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Offerings – Revenue and Forecast to 2028 (US$ Million)
Table 90. Rest of Europe Gastric Cancer Diagnostic Procedure Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 91. Organic Developments Done by Companies
Table 92. Inorganic Developments Done by Companies
Table 93. Glossary of Terms
LIST OF FIGURES
Figure 1. Europe Gastric Cancer Diagnostic Procedure Market Segmentation
Figure 2. Europe Gastric Cancer Diagnostic Procedure Market, by Country
Figure 3. Europe Gastric Cancer Diagnostic Procedure Market Overview
Figure 4. Europe Gastric Cancer Diagnostic Procedure Market, By Symptom Types
Figure 5. Europe Gastric Cancer Diagnostic Procedure Market, By Country
Figure 6. Europe: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. Europe Gastric Cancer Diagnostic Procedure Market: Impact Analysis of Drivers and Restraints
Figure 9. E
Figure 1. Europe Gastric Cancer Diagnostic Procedure Market Segmentation
Figure 2. Europe Gastric Cancer Diagnostic Procedure Market, by Country
Figure 3. Europe Gastric Cancer Diagnostic Procedure Market Overview
Figure 4. Europe Gastric Cancer Diagnostic Procedure Market, By Symptom Types
Figure 5. Europe Gastric Cancer Diagnostic Procedure Market, By Country
Figure 6. Europe: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. Europe Gastric Cancer Diagnostic Procedure Market: Impact Analysis of Drivers and Restraints
Figure 9. E
